Immunic Inc (NASDAQ:IMUX) will participate in several key conferences in June 2025.
CEO Dr. Daniel Vitt will present at the Jefferies Healthcare Conference on June 5 in New York.
Company representatives will also attend the RSC Symposium in Denmark, UBS Life Sciences Conference in London, BIO International Convention in Boston, EAN Congress in Helsinki, and the ABI Conference in Cambridge.
Presentations and data will cover preclinical and clinical advances for vidofludimus calcium (IMU-838). Full details are at imux.com.